Instituto de Química Avanzada de Cataluña -ko ikertzaileekin lankidetzan egindako argitalpenak (9)

2021

  1. HDAC11 is a novel regulator of fatty acid oxidative metabolism in skeletal muscle

    FEBS Journal, Vol. 288, Núm. 3, pp. 902-919

2019

  1. Screening and preliminary biochemical and biological studies of [RuCl(p-cymene)(N, N-bis(diphenylphosphino)-isopropylamine)][BF4] in Breast Cancer Models

    ACS Omega, Vol. 4, Núm. 8, pp. 13005-13014

2017

  1. Role of the sugar moiety on the opioid receptor binding and conformation of a series of enkephalin neoglycopeptides

    Bioorganic and Medicinal Chemistry, Vol. 25, Núm. 7, pp. 2260-2265

2016

  1. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  2. First-in-class inhibitor of the T cell receptor for the treatment of autoimmune diseases

    Science Translational Medicine, Vol. 8, Núm. 370

  3. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

2015

  1. Modulation of the Interaction between a Peptide Ligand and a G Protein-Coupled Receptor by Halogen Atoms

    ACS Medicinal Chemistry Letters, Vol. 6, Núm. 8, pp. 872-876

2011

  1. Synthesis, biological evaluation and structural characterization of novel glycopeptide analogues of nociceptin N/OFQ

    Organic and Biomolecular Chemistry, Vol. 9, Núm. 17, pp. 6133-6142

2009

  1. Synthesis, conformation, and biological characterization of a sugar derivative of morphine that is a potent, long-lasting, and nontolerant antinociceptive

    Journal of Medicinal Chemistry, Vol. 52, Núm. 9, pp. 2656-2666